Mauna Kea Technologies
Signal active
Organization
Contact Information
Overview
Mauna Kea Technologies is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases thanks to real time in vivo microscopic visualization. The Company’s flagship product, Cellvizio®, has received clearance/approval for a wide range of applications in the United States and more than 40 countries around the World.
About
Industries
Biotechnology, Medical, Medical Device
Founded
2000
Employees
101-250
Headquarters locations
Europe
Social
N/A
Profile Resume
Mauna Kea Technologies headquartered in Europe, operates in the Biotechnology, Medical, Medical Device sector. The company focuses on Biotechnology and has secured $4.8B in funding across 72 round(s). With a team of 101-250 employees, Mauna Kea Technologies is actively contributing to advancements in Biotechnology. Their latest funding round, Series B - Mauna Kea Technologies, raised $30.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
3
Lead Investors
0
Total Funding Amount
$66.9M
Details
1
Mauna Kea Technologies has raised a total of $66.9M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2008 | Early Stage Venture | 30.0M |
Investors
Mauna Kea Technologies is funded by 16 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Psilos Group | - | FUNDING ROUND - Psilos Group | 30.0M |
| Seventure Partners | - | FUNDING ROUND - Seventure Partners | 30.0M |
| Mauna Kea Technologies | - | FUNDING ROUND - Mauna Kea Technologies | 30.0M |
| Creadev | - | FUNDING ROUND - Creadev | 30.0M |
Recent Activity
There is no recent news or activity for this profile.